Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Yeti Holdings
YETI
$3.95B
| $5.65M | ﹤0.01% |
136,680
+98,798
| +261% | +$3.71M |
|
|
P
1527
Everpure Inc
P
$29.9B
| $5.64M | ﹤0.01% |
210,905
+51,109
| +32% | +$1.49M |
|
1528
PUT
Booking.com
BKNG
$161B
| $5.64M | ﹤0.01% |
+70,000
| New | +$5.31M |
|
1529
Qfin Holdings
QFIN
$1.61B
| $5.64M | ﹤0.01% |
276,950
-101,938
| -27% | -$1.51M |
|
1530
PUT
Ulta Beauty
ULTA
$24.3B
| $5.63M | ﹤0.01% |
+12,000
| New | +$5.17M |
|
1531
PUT
Zoom
ZM
$30.6B
| $5.62M | ﹤0.01% |
+83,000
| New | +$6.3M |
|
1532
CALL
Salesforce
CRM
$158B
| $5.61M | ﹤0.01% |
+42,300
| New | +$6.17M |
|
1533
Banco Bradesco
BBD
$36.7B
| $5.6M | ﹤0.01% |
1,946,170
-64,084
| -3% | -$208K |
|
1534
BioCryst Pharmaceuticals
BCRX
$2.4B
| $5.56M | ﹤0.01% |
484,492
+72,976
| +18% | +$910K |
|
1535
ProShares Bitcoin Strategy ETF
BITO
$1.45B
| $5.55M | ﹤0.01% |
532,141
+272,370
| +105% | +$3.04M |
|
1536
PUT
BioNTech
BNTX
$23.5B
| $5.54M | ﹤0.01% |
+36,900
| New | +$5.68M |
|
1537
PUT
AstraZeneca
AZN
$250B
| $5.53M | ﹤0.01% |
+40,750
| New | +$5.11M |
|
1538
PUT
State Street Blackstone Senior Loan ETF
SRLN
$5.34B
| $5.52M | ﹤0.01% |
+135,000
| New | +$5.56M |
|
1539
Diamondrock Hospitality Co
DRH
$2.56B
| $5.49M | ﹤0.01% |
670,818
+36,684
| +6% | +$319K |
|
|
DDL
1540
Dingdong
DDL
$503M
| $5.49M | ﹤0.01% |
1,286,163
+262,770
| +26% | +$1.03M |
|
|
IRRX
1541
DELISTED
Integrated Rail and Resources Acquisition Corp.
IRRX
| $5.48M | ﹤0.01% |
532,400
| – | – |
|
1542
Vaxcyte
PCVX
$8.64B
| $5.46M | ﹤0.01% |
113,852
+53,853
| +90% | +$2.11M |
|
|
NHIC
1543
DELISTED
NewHold Investment Corp. II Class A Common Stock
NHIC
| $5.46M | ﹤0.01% |
548,600
| – | – |
|
1544
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
| $5.46M | ﹤0.01% |
908,182
+342,106
| +60% | +$1.85M |
|
1545
AlTi Global
ALTI
$493M
| $5.46M | ﹤0.01% |
500,000
-345,136
| -41% | -$3.44M |
|
|
JJM
1546
DELISTED
iPath Series B Bloomberg Industrial Metals Subindex Total ReturnSM ETN
JJM
| $5.45M | ﹤0.01% |
85,000
| – | – |
|
|
LTC
1547
LTC Properties
LTC
$2.15B
| $5.44M | ﹤0.01% |
153,241
+14,520
| +10% | +$552K |
|
1548
Virgin Galactic
SPCE
$398M
| $5.44M | ﹤0.01% |
78,199
+19,037
| +32% | +$1.78M |
|
1549
PUT
Cameco
CCJ
$42.4B
| $5.44M | ﹤0.01% |
+240,000
| New | +$5.64M |
|
|
BPMC
1550
DELISTED
Blueprint Medicines
BPMC
| $5.44M | ﹤0.01% |
124,186
+50,317
| +68% | +$2.41M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.